BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Business

  Hemispherx Biopharma, Inc. Announces 2007 Financial Results

  March 18, 2008

   · 

  1 min read
• Business

  Merge Healthcare Announces Delay in Filing 2007 Annual Report

  March 18, 2008

   · 

  1 min read
• Drug Development

  Lev Pharmaceuticals, Inc. Presents Results of Phase III Study Supporting Safety and Efficacy of Cinryze(TM) (C1 inhibitor) as Prophylactic Therapy for HAE; Primary Endpoint Met

  March 18, 2008

   · 

  7 min read
• Drug Development

  Targeted Genetics Corporation Announces Completion of Dosing for the Phase 1/2 Clinical Trial of tgAAC94 for Inflammatory Arthritis

  March 18, 2008

   · 

  5 min read
• Transition Therapeutics Inc. to Present at Cowen & Company 28th Annual Healthcare Conference

  March 18, 2008

   · 

  1 min read
• Business

  MedMira Inc. Announces Second Quarter Results

  March 18, 2008

   · 

  1 min read
• Business

  Perlegen Sciences, Inc. Gains Exclusive Access to Data on Four Million Patients to Enable Personalized Medicine

  March 18, 2008

   · 

  1 min read
• Devgen NV Takes Important Steps Towards Future Growth

  March 18, 2008

   · 

  10 min read
• Business

  Barr Pharmaceuticals, Inc.'s PLIVA, Inc. Subsidiary to Terminate GDR Deposit Agreement and Delist From London Stock Exchange

  March 18, 2008

   · 

  4 min read